Related Experiment Video
Updated: May 18, 2026

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
Effects of mitotane on gene expression in the adrenocortical cell line NCI-H295R: a microarray study
Adrienn Zsippai1, Diana Rita Szabó, Zsófia Tömböl
12nd Department of Medicine, Faculty of Medicine, Semmelweis University, Szentkirályi street 46, H-1088 Budapest, Hungary.
Aim:
The adrenolytic agent mitotane is widely used in the treatment of adrenocortical cancer; however, its mechanism of action is poorly elucidated. We have studied mitotane-induced mRNA expression changes in the NCI-H295R adrenocortical cancer cell line.
Materials & Methods:
Cell viability and hormone assays were used to select the optimal mitotane concentration effectively inhibiting hormone secretion without affecting cell viability. RNA isolated from cultures treated for 48 and 72 h was subjected to Agilent 4×44K microarray platforms. Microarray results were validated by quantitative reverse-transcription PCR.
Results:
Altogether, 117 significantly differentially expressed genes were detected at 48 h and 72 h (p < 0.05) in mitotane-treated samples relative to controls. Three significantly underexpressed genes involved in steroid hormone biosynthesis (HSD3B1, HSD3B2 and CYP21A2) and four significantly overexpressed genes (GDF15, ALDH1L2, TRIB3 and SERPINE2) have been validated.
Conclusion:
Gene-expression changes might be involved in the adrenal action of mitotane and in the inhibition of hormone secretion.
Insights
Mitotane, used for adrenocortical cancer, alters gene expression in adrenal cells. This study identifies specific genes involved in steroid hormone biosynthesis and other functions, shedding light on mitotane's mechanism of action.
Area of Science:
- Endocrinology
- Molecular Biology
- Oncology
Background:
- Mitotane is a key treatment for adrenocortical cancer.
- Its precise mechanism of action remains unclear.
- Understanding mitotane's effects on gene expression is crucial.
Purpose of the Study:
- To investigate mitotane-induced changes in mRNA expression.
- To identify genes affected by mitotane in an adrenocortical cancer cell line.
- To elucidate the molecular mechanisms underlying mitotane's therapeutic effects.
Main Methods:
- Utilized the NCI-H295R adrenocortical cancer cell line.
- Employed microarray analysis (Agilent 4×44K) to assess gene expression.
- Validated key findings using quantitative reverse-transcription PCR.
Main Results:
- Identified 117 differentially expressed genes in mitotane-treated cells.
- Validated underexpression of steroid hormone biosynthesis genes (HSD3B1, HSD3B2, CYP21A2).
- Validated overexpression of genes including GDF15, ALDH1L2, TRIB3, and SERPINE2.
Conclusions:
- Mitotane significantly alters gene expression profiles in adrenocortical cancer cells.
- Observed gene expression changes correlate with mitotane's known effects on hormone secretion.
- These findings provide insights into the molecular basis of mitotane's action.
Related Concept Videos
MicroRNAs
Induced Pluripotent Stem Cells
Somatic cells are...

